Skip to content

Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03124758
Enrollment
354
Registered
2017-04-24
Start date
2010-04-20
Completion date
2011-10-31
Last updated
2017-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory hematology analyzer. Blood samples are collected from healthy volunteers who are enrolled in either a blood draw procedure or a hemodilution procedure wherein blood is repeatedly sampled as the concentration of hemoglobin is reduced in a controlled manner by administering fluids intravenously.

Interventions

DEVICEHemoglobin Sensor ((Rainbow Reusable DCI, DCIP))

Measurement of Noninvasive Hemoglobin (SpHb)

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

A. Hemodilution Test Procedure Inclusion Criteria: * Weight of more than 110 lbs and less than 220 lbs. * Physical status of ASA I of II * Able to read and communicate in English * Has signed written informed consent * Female, non pregnant. Female subjects will be provided with a pregnancy test free of charge.

Exclusion criteria

* Age less than 18 yrs and greater than 35 years * Weight of less than 110 lbs or more than 220 lbs. * Hemoglobin less than 12 g/dL * ASA physical status of III. IV, V. * Pregnant * Subject has known drug or alcohol abuse * Subject has skin abnormalities affecting the digits such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish or acrylic nails. * Subject has experienced a head injury with loss of consciousness within the last year * Subject has known neurological and psychiatric disorder that interferes with the subjects level of consciousness * Known or concurrent chronic usage of psychoactive or anticonvulsive drugs within the last 90 days, or any use in the last 7 day (i.e. tricyclic antidepressants, MAO inhibitors, Lithum, neuroleptics, anxiolytics or antipsychotics, except SSRIs). * Subject has any medical condition which in the judgment of the investigator, renders them inappropriate for participation in this study, such as Reynauds Syndrome. * Hypertension: Systolic BP \>140 mmHg or Diastolic BP \> 90 mmHg. * Baseline heart rate \< 50 bpm. * Inability to tolerate sitting still or minimal movement for up to 90 minutes * Discretion of investigator B. Blood Draw Test Procedure Inclusion Criteria: -Subjects must understand and consent to be in the study.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Sensor by Arms Calculation1-5 hoursAccuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.

Countries

United States

Participant flow

Participants by arm

ArmCount
Noninvasive Hemoglobin Sensor
All subjects are enrolled into the test group and all subjects received the Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI, DCIP)
354
Total354

Baseline characteristics

CharacteristicNoninvasive Hemoglobin Sensor
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
354 Participants
Sex: Female, Male
Female
127 Participants
Sex: Female, Male
Male
227 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 354
serious
Total, serious adverse events
0 / 354

Outcome results

Primary

Accuracy of Sensor by Arms Calculation

Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.

Time frame: 1-5 hours

ArmMeasureValue (NUMBER)
Noninvasive Hemoglobin SensorAccuracy of Sensor by Arms Calculation1.0 g/dL

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026